Wyamine Sulfate

Quick links

Choose a section

Quick links to important sections

Advertisements

Wyamine Sulfate

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Wyamine Sulfate

Property Description
Active ingredient Mephentermine Sulfate
Form Injectable solution (Parenteral), Oral tablets (Historical)
Pharmacological class Sympathomimetic agent, Vasopressor
General Purpose Circulatory support, Blood pressure maintenance
Origin Synthetic (Phenethylamine derivative)

Wyamine Sulfate: Definition and Pharmacological Class

Wyamine Sulfate is the registered trade name for the pharmaceutical compound Mephentermine Sulfate. This substance is chemically defined as a synthetic derivative of phenethylamine and is classified pharmacologically as a potent sympathomimetic agent. Functionally, Mephentermine is categorized as a vasopressor, meaning its primary therapeutic action is to increase blood pressure. The compound is categorized under the ATC code C01CA11, grouped with other adrenergic agents used for cardiovascular support. Although structurally related to the anorectic agent Phentermine, Mephentermine Sulfate’s clinical use is distinct, focusing primarily on circulatory dynamics.

Composition, Form, and Synthetic Origin

The preparation contains Mephentermine Sulfate as its sole active ingredient, positioning it as a single-entity product. The substance is synthesized chemically, not derived from a natural source. Its most critical and common pharmaceutical form is the sterile injectable solution, intended for parenteral routes of administration, such as intravenous or intramuscular injection, which is essential for rapid onset. Historically, oral tablets were also formulated. This immediate-acting form is a distinguishing characteristic, underscoring its role as a prescription-only medication in urgent circulatory situations.

General Purpose as a Circulatory Support Agent

This medication's primary general purpose is to rapidly maintain or restore blood pressure in individuals experiencing hypotensive conditions. It fulfills this general benefit by utilizing its sympathomimetic action to stimulate the release of internal neurotransmitters. This mechanism induces vasoconstriction, or the tightening of blood vessels, alongside a supportive action on the heart muscle’s ability to contract, thereby stabilizing the body's essential circulatory function. Mephentermine functions to raise blood pressure through a direct cardiac effect and peripheral vasoconstriction, helping sustain the necessary blood flow to critical organs.

Advertisements

What side effects are possible with Wyamine Sulfate?

Possible Side Effects and Safety Information

Wyamine Sulfate (Mephentermine Sulfate) is a sympathomimetic agent, and its official safety profile is primarily structured around its effects on the cardiovascular and nervous systems, as documented in regulatory sources.

Officially Documented Adverse Reactions

The regulatory safety classification lists several reactions based on frequency and system-organ class:

  • Common Reactions: Adverse reactions officially classified as common include systemic hypertension (high blood pressure), anxiety, insomnia (difficulty in sleeping), and generalized central nervous system (CNS) stimulation.
  • System-Organ Classes: Effects are also documented across Cardiac Disorders (e.g., tachycardia, reflex bradycardia, arrhythmias), Nervous System and Psychiatric Disorders (e.g., tremor, confusion, drowsiness, hallucinations, psychosis), and Gastrointestinal Disorders (e.g., nausea and vomiting).

Serious Adverse Reactions and Safety Constraints

The official labeling notes a tier of serious adverse reactions that are rare but clinically critical, including the potential for cerebral hemorrhage, pulmonary edema, and severe ventricular arrhythmias (e.g., atrioventricular block).

Specific regulatory limitations define when the risk profile is significantly altered:

  • Drug-Drug Restrictions: Severe, potentially life-threatening hypertension is a documented risk when the medication is administered to individuals who have recently used Monoamine Oxidase Inhibitors (MAOIs). Increased risk of arrhythmias is also noted during anesthesia involving certain halogenated hydrocarbons.
  • Population Safety: Safety considerations are noted for use in pregnancy and lactation, for pediatric patients (where safety and effectiveness are not established), and in patients with pre-existing conditions like hypertension or renal impairment.
  • Exposure Patterns: The official safety profile includes notes on the potential for the development of tolerance and dependence associated with continued exposure to the substance.
Advertisements

Overdose and Emergency Response

The official regulatory description of a Wyamine Sulfate (Mephentermine Sulfate) overdose focuses on severe manifestations resulting from excessive sympathomimetic stimulation. Documented clinical signs include the rapid onset of severe acute hypertension, tachycardia, and palpitations. Central nervous system (CNS) overstimulation is also a characteristic presentation, manifesting as nervousness, excitability, and tremor.

Overexposure carries the risk of life-threatening systemic outcomes. Regulatory labeling explicitly notes the potential for severe complications such as cerebral hemorrhage stemming from uncontrolled hypertension, pulmonary edema, and convulsions. Due to the severity of these potential complications, it is officially mandated to seek immediate medical attention for any suspected overdosage. Individuals experiencing severe symptoms like profound chest pain, confusion, or signs of CNS toxicity must contact emergency services immediately.

Official prescribing information confirms that no specific antidote is known for this overdose. Consequently, management focuses on symptomatic and supportive treatment to stabilize vital functions and control specific severe effects, such as using pharmacological agents to manage extreme hypertension. Hospital monitoring is required for continuous observation and management of acute effects.

Advertisements

Therapeutic Uses of Wyamine Sulfate

What Wyamine Sulfate Treats: Main Uses and Benefits

This agent is used in situations involving certain distressing symptoms related to systemic imbalance caused by very low blood pressure. Specifically, this medication is commonly used to help maintain blood pressure in hypotensive states. It is applied across therapeutic domains involving acute or disruptive symptom patterns, such as addressing severe sudden hypotension and managing hypotension following spinal anesthesia.

Wyamine Sulfate supports the cardiovascular system to help alleviate symptom clusters that may become intense or disruptive and interfere with daily comfort, including profound weakness, dizziness, lightheadedness, and the risk of fainting (syncope). This supportive relief may assist with maintaining a sense of stability when symptoms are more noticeable, particularly in relevant clinical settings such as the perioperative period or drug-induced circulatory compromise.

“This application helps ease the overall symptom burden when acute, clinically important hypotension occurs.”


Quick Fact: Addressing Symptoms of Severe Hypotension


Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for Wyamine Sulfate (Mephentermine Sulfate) strictly defines the populations who can and cannot use the medicine. Use is established primarily for adults experiencing hypotensive states, such as those following spinal anesthesia.

The medicine is contraindicated and must not be used in several groups due to the risk of severe complications. These absolute prohibitions include individuals with ventricular arrhythmias, severe coronary artery disease, or angle-closure glaucoma. It is also prohibited for patients concurrently receiving Monoamine Oxidase Inhibitors (MAOIs), or during procedures involving cyclopropane or halogenated anesthesia.

Usage is restricted or requires specific caution in other populations. The medicine is not recommended for pregnant or lactating individuals, and its role in the management of shock due to blood or fluid loss (hypovolemia) is strictly secondary to fluid replacement therapy. The label states that use in pediatric patients is not established, and specific caution is required for geriatric patients, those with severe renal impairment, or a history of psychiatric disorders.

Advertisements

What should I know about interactions with other medicines?

Wyamine Sulfate Interactions with other medicines and products

Official regulatory documentation classifies the interaction profile of Mephentermine Sulfate based primarily on pharmacodynamic effects and mandated restrictions.

Contraindicated and Restricted Combinations

The most critical interaction involves Monoamine Oxidase Inhibitors (MAOIs), which are formally contraindicated for co-administration due to the serious risk of a hypertensive crisis. A period of 14 days following MAOI discontinuation must elapse before this medication may be administered. Use with Volatile Halogenated Anesthetics (e.g., cyclopropane, halothane) is also restricted due to the documented risk of inducing severe cardiac arrhythmias.

Pharmacodynamic Interactions

Co-administration with agents that share cardiovascular activity may lead to either augmentation or antagonism of the intended effect. Substances like Tricyclic Antidepressants (TCAs) and Oxytocin may augment the blood pressure-raising effect, increasing the risk of hypertension. Conversely, the efficacy of the medication may be reduced when used alongside alpha- or beta-Adrenergic Antagonists (blockers) or Reserpine.

Exposure and Special Considerations

A pharmacokinetic-based interaction is documented with Urinary Acidifying Agents (e.g., Ammonium Chloride, Ascorbic Acid), which are noted to decrease the serum concentration of Mephentermine through altered renal elimination. Additionally, official regulatory information indicates that the dosage requirements for Antidiabetic Agents (e.g., Insulin, oral hypoglycemics) may be altered due to this interaction.

Advertisements

Mechanism of Action

Mobilizing Endogenous Neurotransmitters

Wyamine Sulfate acts as an indirectly-acting sympathomimetic amine by influencing the body's own signaling chemicals. The molecule is transported into sympathetic nerve terminals and subsequently enters storage vesicles via the Vesicular Monoamine Transporter (VMAT). This process induces the rapid displacement and release of stored norepinephrine (NE), a key mediator of the autonomic response, into the synaptic cleft, thereby initiating the full mechanistic cascade.

Driving Cardiovascular and Vascular Tone

Once released, norepinephrine acts on two primary sets of adrenergic receptors: beta1 receptors in the myocardium and alpha1 receptors in vascular smooth muscle. Activation of myocardial beta1 receptors leads to an increase in myocardial contractility (the force of the heart's pump). Concurrently, alpha1 activation causes generalized vasoconstriction (narrowing of the blood vessels), increasing systemic vascular resistance.

Resulting Systemic Hemodynamic Effect

This simultaneous dual-action on cardiac output and peripheral resistance leads directly to an elevation of the systemic arterial blood pressure. This mechanistic chain modulates core cardiovascular and autonomic pathways, producing specific hemodynamic adjustments. The effect's magnitude is constrained by the availability of releasable norepinephrine stores.

Advertisements

Dosage and Administration Information

How to Use Wyamine Sulfate

Wyamine Sulfate, the trade name for Mephentermine Sulfate, is utilized as an acute vasopressor agent. It provides immediate circulatory support in highly supervised clinical environments, such as surgical settings.


Administration Method and Dosage

Administration is parenteral, meaning the medicine is delivered by injection. The routes include intravenous (IV) injection and intramuscular (IM) injection.

Administration Detail General Parameters
Standard Dose Range 30 mg to 45 mg for an initial single adult dose, repeated as necessary.
Dosing Frequency Administered on an as-needed, titration-based schedule, determined by the patient's immediate blood pressure response, rather than fixed intervals.
Prophylactic Use An IM injection of 30 mg to 45 mg may be administered 10 to 20 minutes prior to the commencement of spinal anesthesia.

Preparation and Duration Principles

Certain preparation steps are typically employed for use. If the high-concentration solution is to be given as an IV infusion, it is first diluted into an intravenous fluid, such as 5% Dextrose in Water (D5W), to yield a 0.1% solution.

The usage pattern is defined as acute and short-term, reflecting the drug's intended action for immediate stabilization. The duration of effect is approximately 30 minutes following IV administration and up to 4 hours following IM administration, which governs its use for immediate circulatory needs. Use in patients under 18 years of age is generally not recommended.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Wyamine Sulfate

Research Exploring Hypotension Following Spinal Anesthesia

The research base for Mephentermine Sulfate (Wyamine Sulfate) has extensively studied the agent in a specific clinical context: addressing acute drops in blood pressure, known as hypotension, that may occur following spinal anesthesia. Studies were conducted using comparative clinical trials, known as Randomized Controlled Trials (RCTs), where this medicine was evaluated alongside other agents used for blood pressure support. The studies included primarily adult populations, particularly pregnant women (parturients) undergoing elective surgical procedures under spinal anesthesia.

Researchers monitored outcomes related to systemic or functional imbalance, specifically measuring immediate changes to key blood pressure levels (Systolic, Diastolic, and Mean Arterial Pressure) to gauge patterns observed in the studies regarding hemodynamic stability. In the obstetric trials, the research also explored endpoints related to fetal status, such as Apgar scores. These findings describe patterns observed in the studies examining blood pressure during this acute circulatory event.

Research Exploring General Acute Circulatory Support

Research examined the general application of Mephentermine Sulfate to maintain or restore blood pressure in other acute hypotensive states not related to anesthesia. This category of evidence relies heavily on older clinical studies, regulatory submissions dating back to the drug's early approval, and some contemporary observational data.

Mephentermine Sulfate was studied in adult populations with temporary physiological imbalance, where research explored outcomes that reflect episodic or acute changes in blood pressure. The research monitored blood pressure increase and assessed effects on cardiac output. These data show patterns related to short-term changes in blood flow during crises.

What Remains Uncertain About Wyamine Sulfate Research

The research is highly focused on a narrow population (spinal anesthesia-related hypotension), meaning the results apply only to the populations studied. For the broader application of general circulatory support, the reliance on older, non-comparative data means that evidence quality varies across studies. Due to the acute nature of the studied conditions, long-term effects are not fully established, and there is a general lack of comparative evidence against newer medications in many clinical scenarios. This research does not include evidence for routine management of certain severe shock types, such as hypovolemic shock.

Key Studies & References

  1. Mephentermine Sulfate Injection Prescribing Information (DailyMed)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Wyamine Sulfate (FAQ)


Q: Does Wyamine Sulfate work right away?

Official regulatory summaries describe the onset of the medicine's effect as immediate when administered intravenously (directly into the vein). If given by intramuscular injection, the effects typically begin to be observed slightly later, within about 5 to 15 minutes.


Q: How long do the effects of Wyamine Sulfate usually last?

According to the official product information, the duration of the blood pressure-raising effect varies by the route of administration. Following an intravenous injection, the effects last for approximately 30 minutes. If the medicine is administered by intramuscular injection, the effect can last for up to 4 hours.


Q: Is Wyamine Sulfate the same as other medicines for low blood pressure?

Wyamine Sulfate (Mephentermine) is not identical to other common vasopressor medicines used for low blood pressure. It is classified as an indirectly-acting sympathomimetic, meaning it works by prompting the body to release its own internal signaling chemicals. Studies have examined its effects compared to other agents like phenylephrine or ephedrine in certain clinical situations.


Q: How is Wyamine Sulfate different from epinephrine?

Official pharmacological information indicates that Wyamine Sulfate is an indirectly-acting drug, working mainly by causing the release of the body's stored norepinephrine. In contrast, epinephrine (adrenaline) is a direct-acting drug that primarily binds to the body's receptors immediately. Both are used to support circulation, but they achieve their effects through different primary mechanisms.


Q: What is the official caution for using Wyamine Sulfate during pregnancy?

Official regulatory summaries state that this medicine is generally not recommended for use in pregnant women. It may be considered only if a healthcare provider determines the potential benefits may outweigh the risks for the mother. The medicine has been specifically studied for low blood pressure occurring after spinal anesthesia in pregnant women.


Q: Can Wyamine Sulfate be used in children?

Official product information advises that the medicine is not recommended for use in patients under 18 years of age. This restriction is based on the lack of established safety and effectiveness data in this particular age group.


Q: What are the requirements to be eligible for Wyamine Sulfate treatment?

The medicine is officially indicated for the treatment of acute, low blood pressure (hypotension). This often applies to urgent situations, such as those that may occur during surgery, following spinal anesthesia, or during other immediate circulatory emergencies. Eligibility is determined by a healthcare provider based on the patient's acute medical status.


Q: What is the general duration of Wyamine Sulfate treatment?

According to the official product summary, Wyamine Sulfate is typically administered for the short-term management of acute hypotensive episodes. It is not intended for long-term or chronic use, but rather for immediate stabilization of circulatory function.


Q: Why is Wyamine Sulfate not recommended for people with pheochromocytoma?

Official information for sympathomimetic drugs indicates a risk of inducing a severe increase in blood pressure, known as a hypertensive crisis, in patients with pheochromocytoma. This risk is due to the drug’s mechanism of increasing circulating levels of blood pressure-raising chemicals (catecholamines).


Q: Can I drive or operate machinery after receiving Wyamine Sulfate?

Due to the potential for side effects such as dizziness, confusion, or restlessness listed in regulatory documents, caution is generally advised. Since the medicine is typically administered in an acute, clinical setting, a healthcare provider determines when a patient is permitted to resume activities that require high mental alertness.


Q: What is the mechanism by which Wyamine Sulfate increases blood pressure?

Official information describes Wyamine Sulfate as a vasopressor that indirectly raises blood pressure. It works by causing the release of the body's own natural neurotransmitter, norepinephrine. This released chemical then acts to stimulate the heart's pump function and causes blood vessels to narrow (vasoconstriction), which together results in an increase in systemic blood pressure.


Q: Are there specific storage instructions for Wyamine Sulfate before administration?

The official product instructions require the injectable solution to be stored at a Controlled Room Temperature, specifically between 20 C and 25 C. It must be kept protected from freezing. Healthcare providers are also advised to check that the solution is clear and colorless before it is administered.


Q: What is the potential for Wyamine Sulfate to cause headaches?

Yes, headaches are listed among the potential adverse reactions of this medication in some official safety summaries.


Q: Does Wyamine Sulfate affect sleep patterns?

Official safety documents list both insomnia (difficulty in sleeping) and drowsiness as potential side effects of this medicine. These effects relate to the drug's action as a central nervous system stimulant.


Q: What happens if I miss a scheduled dose of Wyamine Sulfate?

Because this medicine is administered in a supervised medical setting by a healthcare professional, the dosing is carefully managed. Official guidelines note that because the medicine is managed by a healthcare professional, they would follow established protocol, which involves administering the dose as soon as recognized, but without doubling the dosage.


Q: Are there any common misconceptions about how Wyamine Sulfate works?

While Wyamine Sulfate is chemically related to certain stimulants, it is used primarily in clinical settings for its action on blood pressure. Its sympathomimetic properties, which are similar to adrenaline, have led regulatory bodies like the World Anti-Doping Agency (WADA) to include it on lists of banned substances due to its potential for non-medical performance-enhancing use.


Q: Does Wyamine Sulfate interact with common pain relievers like ibuprofen?

Official drug interaction checkers note that combining sympathomimetic agents, such as Wyamine Sulfate, with non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of serious cardiovascular events. A healthcare provider may need to monitor the patient's condition when this combination is used.


Q: Why does Wyamine Sulfate have a restricted distribution?

The medicine is primarily used for acute, urgent conditions, such as sudden drops in blood pressure during surgery or other critical emergencies. It is intended to be administered only by qualified healthcare professionals under strict medical supervision in a clinical setting. This need for acute and controlled administration restricts its distribution.


Q: Is there a generic version of Wyamine Sulfate available?

Wyamine Sulfate is the trade name for the active ingredient Mephentermine Sulfate. While the active compound is well-known in regulatory systems, the availability of generic forms and specific trade names can vary significantly depending on the country and regional drug market.


Q: What are the official sources for Wyamine Sulfate patient information?

Authoritative and reliable patient information for this medicine can be found in documents published by government drug regulatory agencies. These include documents from the U.S. FDA (DailyMed), Health Canada, the European Medicines Agency (EMA), and the National Institutes of Health (NIH).


Q: Are there research trials ongoing for new uses of Wyamine Sulfate?

Ongoing research concerning the use of the medicine is typically listed on government trial registries. For instance, recent studies have been registered to compare the hemodynamic stability of Mephentermine against other vasopressors in patients undergoing elective surgery under spinal anesthesia.


Q: What does 'contraindication' mean in the context of Wyamine Sulfate?

A contraindication is a clear reason why a medical treatment must not be used because it would cause the patient harm. For Wyamine Sulfate, official regulatory documents list contraindications such as severe pre-existing heart conditions or concurrent use of other specific medicines like Monoamine Oxidase Inhibitors (MAOIs).


Q: Can Wyamine Sulfate affect kidney function?

Official regulatory information advises caution when using this medicine in individuals with pre-existing severe renal impairment (kidney damage) because the drug's elimination may be altered. Additionally, some literature has explored the potential for acute kidney injury in association with non-medical use of the drug.

Advertisements

How should Wyamine Sulfate be stored and disposed of?

Storage Conditions and Disposal Protocols

Wyamine Sulfate (mephentermine sulfate) injection must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be protected from freezing and should not be used if it appears discolored or contains precipitate.

Store the product in its original container and keep it out of the reach of children.

Since this is a single-use product, any unused portion remaining in the vial or ampule must be immediately discarded. All waste materials and unused medicine must be disposed of in accordance with local regulations. Used needles and syringes should be placed in a dedicated sharps disposal container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Wyamine Sulfate found in:

A-Z Index: